UK health committee to investigate pharma regulation after Brexit

27-09-2017

UK health committee to investigate pharma regulation after Brexit

georgeclerk / iStockphoto.com

The UK’s House of Commons has launched an investigation into post-Brexit regulatory agreements needed to guarantee the safe and effective supply of medicines and medical devices.


Brexit, European Union, medical devices, pharmaceuticals, regulation, NHS, biotech

LSIPR